Alliance Pharma plc (AIM: APH) is an international healthcare group, headquartered in the UK with subsidiaries in Europe, the Far East and the US and wide international reach through an extensive network of distributors, generating sales in more than 100 countries.
Alliance Pharma hold the marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are managed on a portfolio basis according to their growth potential. Promotional investment is focused primarily on our Consumer healthcare brands, many of which have significant international or multi-territory reach.
Prescription Medicines are generally sold in a more limited number of local markets, and most require little or no promotional investment.
The strategy allows us to deliver good organic growth and to enhance our growth rate through carefully selected acquisitions.